- Home
- OBIO vs ASM Comparison
OBIO vs ASM Comparison
Compare OBIO & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ASM
- Stock Information
- Founded
- OBIO 2017
- ASM 1968
- Country
- OBIO United States
- ASM Canada
- Employees
- OBIO N/A
- ASM N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ASM Metal Mining
- Sector
- OBIO Health Care
- ASM Basic Materials
- Exchange
- OBIO Nasdaq
- ASM Nasdaq
- Market Cap
- OBIO 156.6M
- ASM 146.2M
- IPO Year
- OBIO N/A
- ASM N/A
- Fundamental
- Price
- OBIO $5.28
- ASM $1.10
- Analyst Decision
- OBIO Strong Buy
- ASM Strong Buy
- Analyst Count
- OBIO 5
- ASM 2
- Target Price
- OBIO $15.80
- ASM $1.80
- AVG Volume (30 Days)
- OBIO 182.8K
- ASM 1.2M
- Earning Date
- OBIO 11-12-2024
- ASM 11-12-2024
- Dividend Yield
- OBIO N/A
- ASM N/A
- EPS Growth
- OBIO N/A
- ASM 144.19
- EPS
- OBIO N/A
- ASM 0.02
- Revenue
- OBIO $2,647,000.00
- ASM $54,326,000.00
- Revenue This Year
- OBIO $22.61
- ASM $40.31
- Revenue Next Year
- OBIO $16.64
- ASM $33.83
- P/E Ratio
- OBIO N/A
- ASM $43.14
- Revenue Growth
- OBIO N/A
- ASM 18.08
- 52 Week Low
- OBIO $3.96
- ASM $0.44
- 52 Week High
- OBIO $10.06
- ASM $1.56
- Technical
- Relative Strength Index (RSI)
- OBIO 50.69
- ASM 60.13
- Support Level
- OBIO $5.00
- ASM $0.88
- Resistance Level
- OBIO $5.70
- ASM $1.21
- Average True Range (ATR)
- OBIO 0.57
- ASM 0.06
- MACD
- OBIO 0.05
- ASM 0.03
- Stochastic Oscillator
- OBIO 56.41
- ASM 69.44
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.